Keywords: sirtris, srt501, shows, potential, optic, neuritis, model

Sirtris' SRT501 shows potential in optic neuritis model

Article | 15 October 2007

Print This

US biopharmaceutical company Sirtris Pharmaceuticals says that activation of the sirtuin enzyme, SIRT1, was shown to be neuroprotective in an ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in